In contrast to these results, but consistent with recent observations in peritoneal mesotheliomas [13], we found loss of p16 expression in all cases with homozygous CDKN2A deletion determined by CNV analysis. This evidence concerns the gene CDKN2A and peritoneal mesothelioma.